Publicacións en colaboración con investigadores/as de Vall d'Hebron Institut de Recerca (26)

2023

  1. Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis

    The Lancet Regional Health - Europe, Vol. 34

  2. Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 150-162

  3. The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)

    Frontiers in Microbiology, Vol. 14

2022

  1. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

    JHEP Reports, Vol. 4, Núm. 5

  2. Justification for 24/7 clinical microbiology services

    Enfermedades Infecciosas y Microbiologia Clinica

  3. Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations

    Cells, Vol. 11, Núm. 13

  4. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

  5. Relationship among Streptococcus gallolyticus Subsp. gallolyticus, Enterococcus faecalis and Colorectal Neoplasms in Recurrent Endocarditis: A Historical Case Series

    Journal of Clinical Medicine, Vol. 11, Núm. 8

2021

  1. Prevalence of Colorectal Neoplasms Among Patients With Enterococcus faecalis Endocarditis in the GAMES Cohort (2008–2017)

    Mayo Clinic Proceedings, Vol. 96, Núm. 1, pp. 132-146

2020

  1. Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure

    Antiviral Research, Vol. 174

  2. Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome

    Scientific Reports, Vol. 10, Núm. 1

  3. Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel Syndrome

    The American journal of gastroenterology, Vol. 115, Núm. 12, pp. 2047-2059

2019

  1. Mucosal RNA and protein expression as the next frontier in IBS: Abnormal function despite morphologically intact small intestinal mucosa

    American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 316, Núm. 6, pp. G701-G719

2018

  1. A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies

    Advances in Therapy, Vol. 35, Núm. 3, pp. 289-310

  2. Decreased TESK1-mediated cofilin 1 phosphorylation in the jejunum of IBS-D patients may explain increased female predisposition to epithelial dysfunction

    Scientific Reports, Vol. 8, Núm. 1

  3. Epithelial immunity: Priming defensive responses in the intestinal mucosa

    American Journal of Physiology - Gastrointestinal and Liver Physiology

2017

  1. Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study

    United European Gastroenterology Journal, Vol. 5, Núm. 6, pp. 887-897

  2. FIRST CASES OF SEVERE FLACCID PARALYSIS ASSOCIATED WITH ENTEROVIRUS D68 INFECTION IN SPAIN, 2015–2016

    Pediatric Infectious Disease Journal, Vol. 36, Núm. 12, pp. 1214-1216

  3. MiR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea

    Gut, Vol. 66, Núm. 9, pp. 1597-1610

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy